← All candidates
No insider filings on record.
1 filing on record.
CRDLCardiol Therapeutics Inc.
—
$1.84
-4.84% today
No insider filings on record.
Cardiol Therapeutics Inc. hasn't reported Form 4 activity yet.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Short % float
Pro
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
No insider transactions on file for CRDL yet.
Context
Wall St
$8.38 avg target
+355.8% vs today · 5 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q2 '26−$0.05 act+$0.05
Q1 '26−$0.10 act−$0.01
Q4 '25−$0.07 act+$0.04
Q3 '25−$0.12 act−$0.01
Coverage
Is Cardiol Therapeutics (CRDL) Stock Outpacing Its Medical Peers This Year?Zacks · 4w agoCardiol Therapeutics Inc. (CRDL) is a Great Momentum Stock: Should You Buy?Zacks · 08-24Cardiol Therapeutics Advances CardiolRx in Pivotal Phase III Pericarditis TrialMarketBeat · 08-12Here's Why We're Watching Cardiol Therapeutics' (TSE:CRDL) Cash Burn SituationSimply Wall St. · 05-15
The file stays open
1 filing on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice